RxKinetix, Inc.

Mar 01, 06
	NEW STORY
08:07 ET	RxKinetix Completes Its End of Phase 2 Meeting With the FDA for RK-0202 in Oral Mucositis and is Moving Into Phase 3
Jan 12, 06
16:28 ET	RxKinetix Receives University of Colorado Technology Transfer Life Sciences Company of the Year Award
Nov 02, 05
08:32 ET	RxKinetix and Indian Immunologicals Limited Collaborate on Development of Thermostable Hepatitis B Vaccines
Oct 18, 05
08:34 ET	RxKinetix Successfully Concludes Its Phase 2 Trial in Oral Mucositis
Jun 30, 05
20:35 ET	RxKinetix Has Been Offered a Grant From the Prestigious Grand Challenges in Global Health Initiative to Develop Vaccines With Improved Stability at Non-Refrigerated Temperatures